Holen Sie sich die Stockscreener-App
4.6899
2.85%
0.1298
Handel nachbörslich:
4.66
-0.0299
-0.64%
Schlusskurs vom Vortag:
$4.5601
Offen:
$4.73
24-Stunden-Volumen:
46,499
Relative Volume:
3.25
Marktkapitalisierung:
$25.65M
Einnahmen:
$326.00K
Nettoeinkommen (Verlust:
$-20.89M
KGV:
-6.0908
EPS:
-0.77
Netto-Cashflow:
$-18.34M
1W Leistung:
+2.00%
1M Leistung:
-9.64%
6M Leistung:
-18.44%
1J Leistung:
-0.64%
1-Tages-Spanne:
$4.332
$4.75
1-Wochen-Bereich:
$4.332
$5.008
52-Wochen-Spanne:
$3.7728
$8.48
Pluri Inc Stock (PLUR) Company Profile
Firmenname
Pluri Inc
Sektor
Branche
Telefon
972-74-710-7171
Adresse
MATAM ADVANCED TECHNOLOGY PARK, HAIFA
Pluri Inc Aktie (PLUR) Neueste Nachrichten
Pluri And Bar-Ilan University Partner To Advance MAIT Cell Therapy For Solid Tumors - Contract Pharma
Pluri Flat on Funding From Innovation Authority - Baystreet.ca
Pluri Collaborates with Bar-Ilan University to Advance - GlobeNewswire
Pluri Collaborates with Bar-Ilan University to Advance Cancer Immunotherapy for Solid Tumors, Supported by Israel Innovation Authority - StockTitan
Cell And Gene Therapy Contract Development And Manufacturing - openPR
Renaissance Technologies LLC Decreases Position in Pluri Inc. (NASDAQ:PLUR) - Defense World
(PLUR) Technical Pivots with Risk Controls - Stock Traders Daily
Plurilock (PLUR.V) lands $19 million deal, largest in their history - Equity.Guru
Pluri Inc. regains compliance with Nasdaq listing rules - Investing.com India
Pluri Inc. regains compliance with Nasdaq listing rules By Investing.com - Investing.com UK
TomTom (OTCMKTS:TMOAF) Short Interest Down 34.8% in September - Defense World
(PLUR) Proactive Strategies - Stock Traders Daily
The Plurilock (PLUR.V) rip is over: But is that the end of the play? - Equity.Guru
Plurilock’s Behavioral Biometrics: Next-Gen Cybersecurity with Scott Meyers - The Deep Dive
Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing - Yahoo Finance
Plurilock Security joins forces with cloud platform for data protection - Mugglehead
Cell Therapy Manufacturing Market Size Projected to Reach - GlobeNewswire
Ever After Foods receives $10 million investment - Food Business News
Former CrowdStrike Director Reveals Plurilock’s Potential - The Deep Dive
Stem Cell Therapy Market Set to Skyrocket to $48.89 Billion by 2033, Fueled by 13.2% CAGR - BioSpace
Pluri Unveils Proprietary 3D Cell Expansion Technology - Contract Pharma
Cyber Warfare: Ex-CIA Officer Warns of New Global Conflict, With Bryan Cunningham of Plurilock Security - The Deep Dive
Pluri (NASDAQ:PLUR) versus Tarsus Pharmaceuticals (NASDAQ:TARS) Critical Review - American Banking and Market News
(PLUR) Trading Advice - Stock Traders Daily
Critical Survey: Tevogen Bio (NASDAQ:TVGN) versus Pluri (NASDAQ:PLUR) - Defense World
Spanish seafood processors slam plant-based seafood labeling practices; Steakholder Foods signs MoU with Sherry Herring - SeafoodSource
Spanish seafood processors slam plant-based seafood labeling practices; Tender Food products now in Clover locations - SeafoodSource
Pluri Inc. faces potential Nasdaq delisting over equity shortfall - Investing.com
Pluri Inc. faces potential Nasdaq delisting over equity shortfall By Investing.com - Investing.com Canada
400% Stock Surge: What’s Next for Plurilock Security? | Ali Hakimzadeh - The Deep Dive
Pluri enters deal to manufacture Kadimastem’s AstroRx for ALS - ALS News Today
Pluri signs tech transfer, manufacturing agreement with Kadimastem - TipRanks
Pluri’s CDMO To Manufacture Kadimastem’s Cell Therapy Candidates - Contract Pharma
Pluri’s CDMO Selected to Manufacture Kadimastem’s Novel Cell Therapy Product Candidates - Morningstar
(PLUR) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Joe Sexton: Enhancing Plurilock’s Vision with Decades of Experience - The Deep Dive
Contrasting Pluri (NASDAQ:PLUR) & Relay Therapeutics (NASDAQ:RLAY) - American Banking and Market News
Plurilock Appoints Palantir Senior Advisor To Company’s Industry Advisory Council - The Deep Dive
Critical Comparison: Pluri (NASDAQ:PLUR) & Relay Therapeutics (NASDAQ:RLAY) - Defense World
Pluri (NASDAQ:PLUR) Trading 0.3% Higher - Defense World
Pluristyx Announces License Agreement with Humacyte to Develop BioVascular Pancreas using iPSCs - Business Wire
Pluri Inc partners to boost global vegetable supply - Investing.com India
Pluri Inc partners to boost global vegetable supply By Investing.com - Investing.com Canada
Morgan Stanley raises TSMC shares target on strong demand outlook By Investing.com - Investing.com India
Seagate stock target raised, maintains Neutral stance on financial performance By Investing.com - Investing.com India
Strategic Agreement Sparks Market Interest In Pluri (PLUR) Stock - State Reviewer
Pluri Announces €1 Million Proof of Concept Agreement to Enhance Global Sustainable Vegetable Supply - StockTitan
Pluri announces proof of concept agreement with an agriculture corporation - TipRanks
Turnaround Tale: Why Plurilock (PLUR.V) sucked, and what it’s done to fix itself - Equity.Guru
BioCentriq Enhances Partnership With Pluristyx - Contract Pharma
Pluri Inc. appoints new CFO as current officer resigns By Investing.com - Investing.com South Africa
Finanzdaten der Pluri Inc-Aktie (PLUR)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):